Dr Mansukh Mandaviya launches National Policy on Research and Development and Innovation in Pharma-MedTech Sector in India and Scheme for promotion of Research and Innovation in Pharma MedTech Sector (PRIP)

“Today is a historic day, an inflection point in the journey of "Atmanirbharta" in the pharma & medical devices sector. We need to transform Indian Pharma & MedTech sectors from a cost-based to a value-based & innovation-based industry.”

Related Keywords

Vizag ,Andhra Pradesh ,India ,Tamil Nadu ,Uttar Pradesh ,Madhya Pradesh ,Himachal Pradesh ,Pharma Deptt ,Rajiv Bahl ,Indian Pharma Medtech ,Mansukh Mandaviya ,National Institutes Of Pharmaceutical Education ,Parliamentary Standing Committee ,Health Family Welfare ,Ministry Of Health ,Member Health ,Pharmaceuticals Medical Devices ,Ministry Of Chemicals ,Development Of Research ,Indian Council Of Pharmaceuticals ,Research Nipers ,National Policy On Research ,Promotion Of Research ,Department Of Pharmaceuticals ,Indian Pharma ,Union Minister ,Family Welfare ,National Policy ,Pharma Medtech Sector ,Director General ,Jai Jawan ,Jai Kisan ,Jai Vigyan ,Jai Anusandhan ,Pharma Medtech ,Business Rules ,National Institutes ,Pharmaceutical Education ,Medical Devices ,Indian Council ,Med Tech Research ,Pharma Med Tech ,Indian Pharmaceutical ,These Coes ,New Chemical Entities ,